Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 01, 2026
Fred Hutch study dramatically expands therapeutic range of approved kinase drugs
Large-scale analysis reveals new uses for existing therapies across cancer types and non-cancer diseases
Oncology Insights with Dr. Petros Grivas - Episode 11
Inside the science changing lung cancer treatment
Can you get a cancer screening without insurance?
Uninsured? Underinsured? Mammograms and other preventive cancer screenings are still available
Oncology Insights with Dr. Petros Grivas - Episode 9
Making more lung tumors immunotherapy‑sensitive with Dr. Christina Baik
The Beam: Lung and breast cancer screening and prevention; heart health nutrition advice; meet a new child life specialist
What are some cancer prevention steps you can take? Tips on heart-healthy nutrition after treatment; meet Katy Tenhulzen, CCLS
Foot on the gas: How RIT1 and YAP accelerate lung adenocarcinoma
From the Berger Lab, Human Biology Division
Lack of insurance, follow-ups undercut cancer screening wins
Large multi-institution PROSPR II study finds big gaps in access, timely care in cervical, colorectal and lung cancers across U.S.
The Beam: New lung cancer research, meals while away from home, meet our new head-and-neck cancer expert
Fred Hutch expert weighs in on recent ASTRO conference, nutrition and cooking tips, meet Dr. Paul Riviere
After an unexpected diagnosis and surgical complications, a Whitman College professor sought care at Fred Hutch – Proton Therapy
Proton therapy was the easiest part of treatment for a thymic cancer patient with underlying multiple sclerosis
Dr. Jingyi Jessica Li named Donald and Janet K. Guthrie Endowed Chair in Statistics
Funding will help new program head expand applied use of statistics in cancer research
Are we ready for multi-cancer detection tests?
Blood-based cancer tests are coming, but questions about efficacy, reimbursement and diagnostic pathways are far from settled
Whole-body MRI and cancer screening
A perspective from radiologists at Fred Hutch Cancer Center and UW Medicine
Every mile counts: Thousands unite for Fred Hutch Obliteride
More than 5,000 cyclists, walkers, runners and volunteers brought color, energy and connection to Fred Hutch Cancer Center’s annual bike ride and walk/run
How a patient’s stroke led to discovering cancer
Proton therapy was the best treatment choice for patient with lung cancer
Fred Hutch study finds genetic driver of drug resistance in small cell lung cancer
Researchers use CRISPR-Cas9 gene-editing tool on tumor cells grown in mice to better model how tumors that initially respond to chemotherapy become resistant